Back to search

Peptide record

TPDB65947

Tumor-homing Peptides standard
31 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB65947
Tumor-homing Peptides
Cancer-related peptides
TumorHoPe2.0
standard
No
A 31-aa standard natural tumor-homing peptides peptide sequence curated from TumorHoPe2.0, with an available 3D structural model.
Sequence
RCSHYTGIRCSHMAATTAGIYTGIRCQHVVL
Physicochemical Analysis
C144H233N47O41S4
NDEKFPW
T
3406.96
9.12
6
0
12
+3
2.05
0.184
78.71
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
3105
91.14
12
Residue Composition
number
3
A
3
R
0
N
0
D
3
C
0
E
1
Q
3
G
3
H
3
I
1
L
0
K
1
M
0
F
0
P
2
S
4
T
0
W
2
Y
2
V
Amino Acid Distribution
A: 3 R: 3 N: 0 D: 0 C: 3 E: 0 Q: 1 G: 3 H: 3 I: 3 L: 1 K: 0 M: 1 F: 0 P: 0 S: 2 T: 4 W: 0 Y: 2 V: 2
Chemical Descriptors
31
C144H233N47O41S4
3406.96
9.12
+3
2.05
0.184
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

Tumor cell
Targeting
EGFR

Source & Reference

TumorHoPe2.0
TumorHoPe2
Tumor targeting polypeptide and method of use thereof
2023
US 11566045 B2
US 11566045 B2

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
Synthetic
Linker peptide (HMAATT), chemotherapeutic agent (capecitabine, cisplatin, trastuzumab, fulvestrant, tamoxifen, letrozole, exemestane, anastrozole, aminoglutethimide, testolactone, vorozole, formestane, Fadrozole, letrozole, erlotinib, lafatinib, dasatinib, gefitinib, imatin, Imatinib, pazopinib, lapatinib, sunitinib, nilotinib, sorafenib, nab-palitaxel), radiotherapeutic agent (iodine-131, lutetium-177, yttrium-90, samarium-153, phospho-32, cesium-131, palladium-223, iodine-125, boron-10, actinium-225, bismuth-213, radium-225, lead-212, thorium-232)
Additional Detail Fields 1 fields
Linker peptide (HMAATT), chemotherapeutic agent (capecitabine, cisplatin, trastuzumab, fulvestrant, tamoxifen, letrozole, exemestane, anastrozole, aminoglutethimide, testolactone, vorozole, formestane, Fadrozole, letrozole, erlotinib, lafatinib, dasatinib, gefitinib, imatin, Imatinib, pazopinib, lapatinib, sunitinib, nilotinib, sorafenib, nab-palitaxel), radiotherapeutic agent (iodine-131, lutetium-177, yttrium-90, samarium-153, phospho-32, cesium-131, palladium-223, iodine-125, boron-10, actinium-225, bismuth-213, radium-225, lead-212, thorium-232)